Delta Medical International have been supplying 24% sucrose solution to the NHS for pain management in babies for some time. An increasing number of hospitals are choosing Delta’s product not only for its efficacy but also due to the savings in cost it can deliver.
Whilst sucrose might not be a large part of budget spend in Neonatal Units (NICU, SCBU, etc) and maternity departments, it is an ongoing cost and the principle of “every little helps” is becoming more widely recognised as an essential part of meeting ever more challenging financial targets. Part of Delta Medical’s philosophy is to work with its NHS customers to help deliver cost savings without compromising quality of care. Many of the company’s product ranges can contribute in this way, including sterile saline wipes, phototherapy accessories, gel positioners, transcutaneous jaundice meters (bilirubnometers) and more.
The sucrose solution ampoules have been designed to allow precise dosage, easily administered one drop at a time and directed to the tongue for greatest efficacy. The ampoules can be easily stood once opened, to avoid waste, and are designed to minimise the risk of contamination.
A number of hospital neonatal and maternity units have switched to Delta’s 24% sucrose solution due to the advantages mentioned above. Their repeat ordering patterns bear testament to the efficacy and ease of use, with the cost savings bringing a bonus to users who have switched from other brands.
More information can be found on our Product page and we would be delighted to discuss the benefits of our sucrose solution, the latest research on glucose as an alternative and the cost benefits with any departments – just contact us.
